Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-02-06 @ 6:19 AM
Study NCT ID:
NCT04300803
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2020-08-28
First Post:
2020-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL
Sponsor:
Organization: